40.3% Below Target

The consensus Wall Street price target for NRDS is $13.33, representing 40.3% upside from the current price of $9.5. With 6 analysts covering the stock, this strong upside suggests significant value not yet reflected in today's share price.

NRDS has a consensus rating of "Buy" based on 6 Wall Street analysts. The rating breakdown is predominantly bullish, with 4 Buy/Strong Buy ratings. The consensus 12-month price target of $13.33 implies 40.3% upside from current levels.

With a forward P/E of 10.4361x, NRDS trades at a relatively low valuation. The consensus target of $13.33 implies 40.3% appreciation, suggesting meaningful undervaluation.

The most bullish Wall Street analyst has a price target of $15 for NRDS, while the most conservative target is $12. The consensus of $13.33 represents the median expectation. Our quantitative valuation model projects a bull case target of $22 based on optimistic growth and margin assumptions. These targets typically reflect 12-month expectations.

NRDS is moderately covered, with 6 analysts providing price targets and ratings. Of these, 0 have Strong Buy ratings, 4 have Buy ratings, 1 recommend Hold, and 1 have Sell or Strong Sell ratings. Higher analyst coverage generally indicates greater institutional interest and more reliable consensus estimates.

The 12-month NRDS stock forecast based on 6 Wall Street analysts shows a consensus price target of $13.33, with estimates ranging from $12 (bear case) to $15 (bull case). The median consensus rating is "Buy". Our proprietary valuation model produces a base case fair value of $17, with bear/bull scenarios of $10/$22.

Our quantitative valuation model calculates NRDS's fair value at $17 (base case), with a bear case of $10 and bull case of $22. The model uses discounted cash flow analysis, historical growth rates, and margin mean-reversion to project FY+2 earnings, then applies an appropriate P/E multiple. The model confidence score is 57/100.

NRDS trades at a forward P/E ratio of 10.4x based on next-twelve-months earnings estimates compared to a trailing P/E of 14.8x. The lower forward P/E indicates analysts expect earnings growth. A forward P/E is useful for comparing valuations when earnings are expected to change significantly.

Wall Street analysts are very optimistic on NRDS, with a "Buy" consensus rating and $13.33 price target (40.3% upside). 4 of 6 analysts rate it Buy or Strong Buy. This information is for educational purposes only. Always conduct your own research, consider your financial situation, and consult a financial advisor before making investment decisions.

NRDS analyst price targets range from $12 to $15, a 23% tight range reflecting strong analyst consensus. Differences stem from varying assumptions about revenue growth, profit margins, competitive dynamics, and valuation multiples. The $13.33 consensus represents the middle ground. Our model's $10-$22 range provides an independent fundamental perspective.